Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Goodwill & Intangibles (2016 - 2025)

National Healthcare (NHC) has disclosed Goodwill & Intangibles for 16 consecutive years, with $190.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Goodwill & Intangibles changed 0.0% year-over-year to $190.3 million, compared with a TTM value of $190.3 million through Dec 2025, changed 0.0%, and an annual FY2025 reading of $190.3 million, changed 0.0% over the prior year.
  • Goodwill & Intangibles was $190.3 million for Q4 2025 at National Healthcare, roughly flat from $190.3 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $190.3 million in Q4 2024 and bottomed at $168.3 million in Q1 2021.
  • Average Goodwill & Intangibles over 5 years is $177.5 million, with a median of $175.3 million recorded in 2021.
  • The sharpest move saw Goodwill & Intangibles soared 721.58% in 2021, then decreased 2.77% in 2025.
  • Year by year, Goodwill & Intangibles stood at $175.3 million in 2021, then changed by 0.0% to $175.3 million in 2022, then changed by 0.0% to $175.3 million in 2023, then grew by 8.56% to $190.3 million in 2024, then changed by 0.0% to $190.3 million in 2025.
  • Business Quant data shows Goodwill & Intangibles for NHC at $190.3 million in Q4 2025, $190.3 million in Q3 2025, and $170.5 million in Q2 2025.